BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1641656)

  • 1. Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers.
    Kinsella TJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):41-7. PubMed ID: 1641656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical rationale for S-phase radiosensitization in human tumors.
    McGinn CJ; Kinsella TJ
    Curr Probl Cancer; 1993; 17(5):273-321. PubMed ID: 8281809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to the radiosensitization of human tumors.
    Kinsella TJ
    Cancer J Sci Am; 1996; 2(4):184-93. PubMed ID: 9166528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.
    McGinn CJ; Kinsella TJ
    Semin Oncol; 1992 Aug; 19(4 Suppl 11):21-8. PubMed ID: 1509278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimetabolite radiosensitizers.
    Shewach DS; Lawrence TS
    J Clin Oncol; 2007 Sep; 25(26):4043-50. PubMed ID: 17827452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer J Sci Am; 1997; 3(3):163-73. PubMed ID: 9161782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
    Sartor CI
    Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic basis for combining drugs with radiation.
    Wilson GD; Bentzen SM; Harari PM
    Semin Radiat Oncol; 2006 Jan; 16(1):2-9. PubMed ID: 16378901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiosensitization research in cancer therapy].
    Sugahara T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between two radiosensitizers: 5-iododeoxyuridine and caffeine.
    Seo Y; Yan T; Schupp JE; Yamane K; Radivoyevitch T; Kinsella TJ
    Cancer Res; 2006 Jan; 66(1):490-8. PubMed ID: 16397265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
    De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
    Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ.
    Iliakis G; Wu W; Wang M
    Int J Hyperthermia; 2008 Feb; 24(1):17-29. PubMed ID: 18214766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
    McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
    Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation.
    Gurkan E; Schupp JE; Aziz MA; Kinsella TJ; Loparo KA
    Cancer Res; 2007 Nov; 67(22):10993-1000. PubMed ID: 18006845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
    Guichard M; Malaise EP
    Sem Hop; 1980 Jun 8-15; 56(21-24):1094-107. PubMed ID: 6156491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells.
    Iliakis G; Pantelias G; Kurtzman S
    Radiat Res; 1991 Jan; 125(1):56-64. PubMed ID: 1986401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
    Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
    Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.